Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 9, 2014, Pages 5436-5449

  Yuan, Ziming ^a   Zhao, Xin ^b   Wang, Xiaohu ^a   Qiu, Wangwang ^a   Chen, Xinliang ^b   Zheng, Qi ^a   Cui, Wenguo ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Cancer; Electrospun; Hydrophobicity; PLLA; Polydopamine

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ARTIFICIAL MEMBRANE; BAX PROTEIN, HUMAN; BCL2 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASPASE 3; DOXORUBICIN; DRUG CARRIER; DRUG IMPLANT; INDOLE DERIVATIVE; LACTIC ACID; POLYDOPAMINE; POLYLACTIC ACID; POLYMER; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL; APOPTOSIS; ARTIFICIAL MEMBRANE; BAGG ALBINO MOUSE; BREAST NEOPLASMS; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL PHENOMENA; CHEMISTRY; CONFORMATION; DRUG EFFECTS; DRUG IMPLANT; DRUG SCREENING; FEMALE; HUMAN; MEDICINAL CHEMISTRY; METABOLISM; NECROSIS; NUDE MOUSE; PATHOLOGY; SURFACE PROPERTY; TIME FACTOR; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DOXORUBICIN; DRUG CARRIERS; DRUG IMPLANTS; FEMALE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDOLES; LACTIC ACID; MEMBRANES, ARTIFICIAL; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR CONFORMATION; NECROSIS; POLYMERS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURFACE PROPERTIES; TIME FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84911496126     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Sakthivel KM, Guruvayoorappan C. Acacia ferruginea inhibits tumor progression by regulating inflammatory mediators-(TNF-a, iNOS, COX-2, IL-1ß, IL-6, IFN-?, IL-2, GM-CSF) and pro-angiogenic growth factor-VEGF. Asian Pac J Cancer Preve 2013; 14: 3909-3919.
2. Aliperti LA, Predina JD, Vachani A, Singhal S. Local and systemic recurrence is the Achilles heel of cancer surgery. Ann Surg Oncol 2011; 18: 603-607.
3. Hayashi M, Guerrero-Preston R, Okamura J, Michailidi C, Kahn Z, Li X, Ahn J, Goldsmith M, Koch W. Innovative rapid gene methylation analysis of surgical margin tissues in head and neck cancer. Ann Surg Oncol 2014; 21: 3124-3131.
4. Xi L, Zhou G, Gao N, Yang L, Gonzalo DA, Hughes SJ, Jiang H. Photoacoustic and fluorescence image-guided surgery using a multifunctional targeted nanoprobe. Ann Surg Oncol 2014; 21: 1602-1609.
5. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S. Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005; 241: 629-639.
6. Balch GC, Mithani SK, Simpson JF, Kelley MC. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. Am Surg 2005; 71: 22-27.
7. Takenaka K, Yoshida K, Nishizaki T, Korenaga D, Hiroshige K, Ikeda T, Sugimachi K. Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma. Am J Surg 1995; 169: 400-405.
8. Alam N, Darling G, Shepherd FA, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Postoperative chemotherapy in nonsmall cell lung cancer: a systematic review. Ann Thorac Surg 2006; 81: 1926-1936.
9. Hejna M, Wöhrer S, Schmidinger M, Raderer M. Postoperative chemotherapy for gastric cancer. Oncologist 2006; 11: 136-145.
10. Mahato R, Tai W, Cheng K. Pro-drugs for improving tumor targetability and efficiency. Adv Drug Deliv Rev 2011; 63: 659-670.
11. Maretschek S, Greiner A, Kissel T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J Control Release 2008; 127: 180-187.
12. Langer R. New methods of drug delivery. Science 1990; 249: 1527-1533.
13. Li J, Fu R, Li L, Yang G, Ding S, Zhong Z, Zhou S. Co-delivery of dexamethasone and green tea polyphenols using electrospun ultrafine fibers for effective treatment of keloid. Pharm Res 2014; 31: 1632-1643.
14. Reneker DH, Yarin AL, Fong H, Koombhongse S. Bending instability of electrically charged liquid jets of polymer solutions in electrospinning. J Appl Phys 2000; 87: 4531-4547.
15. Thomas V, Dean DR, Jose MV, Mathew B, Chowdhury S, Vohra YK. Nanostructured biocomposite scaffolds based on collagen coelectrospun with nanohydroxyapatite. Biomacro- molecules 2007; 8: 631-637.
16. Martins A, Araújo JV, Reis RL, Neves NM. Electrospun nanostructured scaffolds for tissue engineering applications. Nanomedicine (Lond) 2007; 2: 929-942.
17. Miyazaki H, Kinoshita M, Saito A, Fujie T, Kabata K, Hara E, Ono S, Takeoka S, Saitoh D. An ultrathin poly(L-lactic acid) nanosheet as a burn wound dressing for protection against bacterial infection. Wound Repair Regen 2012; 20: 573-579.
18. Yuan ZM, Zhao JW, Zhu WK, Yang ZL, Li B, Yang HL, Zheng Q, Cui WG. Ibuprofen-loaded electrospun fibrous scaffold doped with sodium bicarbonate for responsively inhibiting inflammation and promoting muscle wound healing in vivo. Biomaterials Science 2014; 2: 502-511.
19. Yuan Z, Zhao J, Chen Y, Yang Z, Cui W, Zheng Q. Regulating inflammation using acid-responsive electrospun fibrous scaffolds for skin scarless healing. Mediators Inflamm 2014; 2014: 858045.
20. Zong XH, Kim K, Fang DF, Ran SF, Hsiao BS, Chu B. Structure and process relationship of electrospun bioabsorbable nanofiber membranes. Polymer 2002; 43: 4403-4412.
21. Bhattarai SR, Bhattarai N, Viswanathamurthi P, Yi HK, Hwang PH, Kim HY. Hydrophilic nanofibrous structure of polylactide; fabrication and cell affinity. J Biomed Mater Res A 2006; 78: 247-257.
22. Cao D, Wu YP, Fu ZF, Tian Y, Li CJ, Gao CY, Chen ZL, Feng XZ. Cell adhesive and growth behavior on electrospun nanofibrous scaffolds by designed multifunctional composites. Colloids Surf B Biointerfaces 2011; 84: 26-34.
23. Sun XM, Cheng LY, Zhao JW, Jin R, Sun BS, Shi YM, Zhang L, Zhang YG, Cui, WG. bFGF-grafted electrospun fibrous scaffolds via poly- (dopamine) for skin wound healing. J Mater Chem B 2014; 2: 3636-3645.
24. Jung HJ, Park K, Kim JJ, Lee JH, Han KO, Han DK. Effect of RGD-immobilized dual-pore poly (L-lactic acid) scaffolds on chondrocyte proliferation and extracellular matrix production. Artif Organs 2008; 32: 981-989.
25. Yang Y, Zhu XL, Cui WG, Li XH, Jin Y. Electrospun composite mats of poly[(D,L-lactide)-co-glycolide] and collagen with high porosity as potential scaffolds for skin tissue engineering. Macromolecular Materials and Engineering 2009; 294: 611-619.
26. Park K, Ju YM, Son JS, Ahn KD, Han DK. Surface modification of biodegradable electrospun nanofiber scaffolds and their interaction with fibroblasts. J Biomater Sci Polym Ed 2007; 18: 369-382.
27. Niwa D, Fujie T, Lang T, Goda N, Takeoka S. Heterofunctional nanosheet controlling cell adhesion properties by collagen coating. J Biomater Appl 2012; 27: 131-141.
28. Yang K, Lee JS, Kim J, Lee YB, Shin H, Um SH, Kim JB, Park KI, Lee H, Cho SW. Polydopamine-mediated surface modification of scaffold materials for human neural stem cell engineering. Biomaterials 2012; 33: 6952-6964.
29. Lee H, Rho J, Messersmith PB. Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings. Adv Mater 2009; 21: 431-434.
30. Xu LQ, Yang WJ, Neoh KG, Kang ET, Fu GD. Dopamine-induced reduction and functionalization of graphene oxide nanosheets. Macromolecules 2010; 43: 8336-8339.
31. Kim JH, Lee M, Park CB. Polydopamine as a biomimetic electron gate for artificial photosynthesis. Angew Chem Int Ed Engl 2014; 53: 6364-6368.
32. Yu J, Wei W, Menyo MS, Masic A, Waite JH, Israelachvili JN. Adhesion of mussel foot protein- 3 to TiO2 surfaces: the effect of pH. Biomacromolecules 2013; 14: 1072-1077.
33. Nielsen SR, Besenbacher F, Chen M. Mussel inspired surface functionalization of electrospun nanofibers for bio-applications. Phys Chem Chem Phys 2013; 15: 17029-17037.
34. Lee H, Dellatore SM, Miller WM, Messersmith PB. Mussel-inspired surface chemistry for multifunctional coatings. Science 2007; 318: 426-430.
35. Cui W, Li X, Zhu X, Yu G, Zhou S, Weng J. Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation. Biomacromo- lecules 2006; 7: 1623-1629.
36. Liu H, Wise SG, Rnjak-Kovacina J, Kaplan DL, Bilek MM, Weiss AS, Fei J, Bao S. Biocom- patibility of silk-tropoelastin protein polymers. Biomaterials 2014; 35: 5138-5147.
37. -δδCT method. Methods 2001; 25: 402-408.
38. Yuan Z, Zhao J, Yang Z, Li B, Yang H, Cui W, Zheng Q. Synergistic effect of regeneration and inflammation via ibuprofen-loaded electrospun fibrous scaffolds for repairing skeletal muscle. European Journal of Inflammation 2014; 12: 41-52.
39. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: po- lylactides (PLA), poly (3-hydroxybutyrate) (PHB), and poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-1148.
40. Shi X, Sun L, Jiang J, Zhang X, Ding W, Gan Z. Biodegradable polymeric microcarriers with controllable porous structure for tissue engineering. Macromol Biosci 2009; 9: 1211-1218.
41. Khorasani MT, Mirzadeh H, Irani S. Plasma surface modification of poly(llactic acid) and poly(lactic-co-glycolic acid) films for improvement of nerve cells adhesion. Radiation Physics and Chemistry 2008; 77: 280-287.
42. Ku SH, Park CB. Human endothelial cell growth on mussel-inspired nanofiber scaffold for vascular tissue engineering. Biomaterials 2010; 31: 9431-9437.
43. Rim NG, Kim SJ, Shin YM, Jun I, Lim DW, Park JH, Shin H. Mussel-inspired surface modification of poly(l-lactide) electrospun fibers for modulation of osteogenic differentiation of human mesenchymal stem cells. Colloids Surf B Biointerfaces 2012; 91: 189-197.
44. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345-357.
45. Reed JC. Mechanisms of apoptosis. Am J Pathol 2000; 157: 1415-1430.
46. Saraswati S, Agrawal SS, Alhaider AA. Ursolic acid (UA) inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor. Chem Biol Interact 2013; 206: 153-165.
47. Looi CY, Moharram B, Paydar M, Wong YL, Leong KH, Mohamad K, Arya A, Wong WF, Mustafa MR. Induction of apoptosis in melanoma A375 cells by a chloroform fraction of Centratherum anthelminticum (L.) seeds involves NF-kappaB, p53 and Bcl-2-controlled mitochondrial signaling pathways. BMC Complement Altern Med 2013; 13: 166.
48. Saha S, Hossain DM, Mukherjee S, Mohanty S, Mazumdar M, Mukherjee S, Ghosh UK, Nayek C, Raveendar C, Khurana A, Chakrabarty R, Sa G, Das T. Calcarea carbonica induces apoptosis in cancer cells in p53-dependent manner via an immuno-modulatory circuit. BMC Complement Altern Med 2013; 13: 230.
49. Florou D, Patsis C, Ardavanis A, Scorilas A. Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells. Cancer Biol Ther 2013; 14: 587-596.
50. Wood DF, Johnston JM, Johnston DG. Do- pamine, the dopamine D2 receptor and pituitary tumors. Clin Endocrinol 1991; 35: 455-466.
51. Grossrubatscher E, Veronese S, Ciaramella PD, Pugliese R, Boniardi M, De Carlis L, Torre M, Ravini M, Gambacorta M, Loli P. High expression of dopamine receptor subtype 2 in a large series of neuroendocrine tumors. Cancer Biol Ther 2008; 7: 1970-1978.
52. Ganguly S, Basu B, Shome S, Jadhav T, Roy S, Majumdar J, Dasgupta PS, Basu S. Dopamine, by acting through its D2 receptor, inhibits insulin- like growth factor-I(IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation. Am J Pathol 2010; 177: 2701-2707.
53. Sheikhpour M, Ahangari G, Sadeghizadeh M, Deezagi A. A novel report of apoptosis in human lung carcinoma cells using selective agonist of D2-like dopamine receptors: a new approach for the treatment of human non-small cell lung cancer. Int J Immunopathol Pharmacol 2013; 26: 393-402.